LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (“Retractable”) (AMEX: RVP), a leading maker of safety needle devices, announced today that a Tyler, Texas jury returned a verdict on Friday, December 18th in the litigation of Retractable Technologies, Inc. v. OMI (Occupational & Medical Innovations Limited, an Australian public company,) in favor of Retractable on all claims presented to the jury. The jury found that OMI’s Auto-Retractable Safety Syringe infringed all the asserted claims under patent 6,572,584 (“the ‘584 patent”), OMI was directed to pay Retractable $1,571,103 for such infringement and found that Retractable’s ‘584 patent is valid and enforceable. In addition, the jury found that OMI misappropriated trade secret information and was directed to pay Retractable $2,240,640 in damages.
